BackLakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Net Tangible Assets

Latest net tangible assets for LSBPW: $500M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$499.75M
↓ 14.60% YoYΔ $-85.45M vs prior year quarter

Peer average

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Net Tangible Assets History

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) vs. peers: Net Tangible Assets Comparison

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (LSBPW) FAQ

As of the most recent data (March 2025), LSBPW shows a net tangible assets of $500M. That compares with $590M in the prior-year period — down 14.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LSBPW's net tangible assets is now $500M (was $590M) — a 14.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is outperforming or lagging.

Tracking LSBPW's net tangible assets over time shows whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $500M That compares with $590M in the prior-year period — down 14.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $500M) with ownership activity and broader fundamentals.